Calendar ASLAN Pharmaceuticals Limited

Equities

ASLN

US04522R2004

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
0.4153 USD -7.30% Intraday chart for ASLAN Pharmaceuticals Limited -18.89% -20.46%

Chart calendar ASLAN Pharmaceuticals Limited

2e6e2fc8484dab856278b6af3ea3.W345_lS11eaVS1zrC-Bo7s7w09LcIVBn74hiHHI7BxU.BEhDzj7aja3NGhSce6Yl16qFgLqqEmc3ptsTfiBaS14LR0mhAo26l9oeZA~39146b46fe7549a637e8e4985b30dc56

Upcoming events on ASLAN Pharmaceuticals Limited

20/05/2024 17:15 American Thoracic Society International Conference - Poster No 13753
12/08/2024 Q2 2024 Earnings Release (Projected)
24/10/2024 Q3 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)

Past events on ASLAN Pharmaceuticals Limited

24/04/2024 Q1 2024 Earnings Release (Projected)
12/04/2024 13:00 Q4 2023 Earnings Release
28/03/2024 12:00 H.C. Wainwright Autoimmune and Inflammatory Disease Conference
09/01/2024 LifeSci Partners Corporate Access Event
07/01/2024 Biotech Showcase
06/01/2024 Dermatology Summit
29/11/2023 16:30 Piper Sandler Healthcare Conference
30/10/2023 Dermatology Drug Development Summit
27/10/2023 13:00 Q3 2023 Earnings Release
24/10/2023 16:00 Investor Meeting - Key Opinion Leader
11/09/2023 15:30 H.C. Wainwright Global Investment Conference
11/08/2023 12:00 Q2 2023 Earnings Release
06/07/2023 13:30 TREK-AD Phase 2b Trial Results Call
08/06/2023 21:30 Jefferies Global Healthcare Conference
13/05/2023 05:15 International Societies for Investigative Dermatology Meeting - Abstract Number : LB1751
09/05/2023 International Societies for Investigative Dermatology Meeting - Abstract Number : LB1777
09/05/2023 International Societies for Investigative Dermatology Meeting - Abstract Number : 657
09/05/2023 International Societies for Investigative Dermatology Meeting - Abstract Number : 1594
28/04/2023 12:00 Q1 2023 Earnings Release
30/03/2023 15:30 H.C. Wainwright Autoimmune & Inflammatory Disease Conference - Fireside Chat

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million TWD
Released
Forecast
Spread
90,7
91,4
-0.81%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
387
379
2.21%

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million TWD
Released
Forecast
Spread
-1 378
-674
-104.55%
-463
-402
-15.28%
-971
-889
-9.19%
-1 451
-1 404
-3.35%
-1 411
-1 321
-6.77%

-2 023

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
-1 410
-682
-106.67%
-477
-427
-11.78%
-906
-850
-6.61%
-1 554
-1 506
-3.23%
-1 422
-1 347
-5.55%

-2 135

Net income
Million TWD
Released
Forecast
Spread
-1 421
-694
-104.65%
-455
-423
-7.7%
-898
-857
-4.76%
-1 557
-1 506
-3.39%
-1 427
-1 350
-5.64%

-2 135

EPS
USD
Released
Forecast
Spread
-7,25
-3,70
-95.95%
-2,00
-1,43
-39.54%
-2,40
-2,38
-0.7%
-3,68
-2,12
-74%
-2,69
-2,61
-3.07%

-3,62

Announcement Date18/03/2022/04/2125/03/2224/03/2312/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million TWD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
381
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million TWD
Released
Forecast
Spread
-319
-258
-23.66%
-349
-291
-19.94%
-369
-372
0.85%
-330
-394
16.46%
-406
-349
-16.18%
-557
-398
-39.89%
-75,2
-479
84.29%
-338
-460
26.43%
-414
-346
-19.63%

-372


-385


-385


-881


-380

Earnings before Tax (EBT)
Million TWD
Released
Forecast
Spread
-262
-268
2.24%
-380
-310
-22.47%
-391
-403
3.07%
-349
-425
17.76%
-436
-378
-15.33%
-588
-423
-39.15%
-58,1
-527
88.97%
-314
-494
36.35%
-435
-381
-14.03%

-399


-412


-413


-911


-420

Net income
Million TWD
Released
Forecast
Spread
-262
-277
5.41%
-380
-310
-22.47%
-391
-419
6.77%
-350
-425
17.69%
-439
-378
-15.97%
-588
-423
-39.2%
-59,9
-496
87.91%
-315
-494
36.16%
-436
-381
-14.37%

-399


-412


-413


-911


-420

EPS
USD
Released
Forecast
Spread
-0,80
-0,72
-11.63%
-0,95
-0,90
-5.56%
-0,95
-0,60
-58.33%
-0,80
-0,95
15.79%
-1,04
-0,55
-90.83%
-1,29
-0,44
-196.55%
-0,11
-0,80
86.25%
-0,56
-0,77
27.27%
-0,79
-0,65
-21.54%

-0,61


-0,54


-0,53


-1,87


-0,56

Announcement Date25/03/2227/04/2212/08/2228/10/2224/03/2328/04/2311/08/2327/10/2312/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ASLN Stock
  4. Calendar ASLAN Pharmaceuticals Limited